ESC Professional Premium Access

Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes

Congress Presentation

About the speaker

Doctor Luca Esposito

San Giovanni di Dio and Ruggi d'Aragona University Hospital, Salerno (Italy)
0 follower

5 more presentations in this session

Association of coagulation markers and antiphospholipid antibodies with ischemic and bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention

Speaker: Ms V. Anfang (Freiburg, DE)

Thumbnail

Epicardial adipose tissue, infarct size, microvascular obstruction and ventricular remodelling after ST-segment elevation myocardial infarction

Speaker: Doctor A. Aimo (Pisa, IT)

Thumbnail

Prognostic implication of residual inflammatory risk according to disease status in patients treated with percutaneous coronary intervention

Speaker: Doctor H. Song (Guang-Myong, KR)

Thumbnail

Platelet extracellular vesicles are superior to cardiac troponin to diagnose acute coronary syndrome with short symptom duration: LEMONADE trial

Speaker: Doctor A. Gasecka (Warsaw, PL)

Thumbnail

Multivessel spontaneous coronary artery dissection: clinical features, angiographic findings, management, and outcomes

Speaker: Doctor J. Salamanca Viloria (Madrid, ES)

Thumbnail

Access the full session

Coronary artery disease - Different aspects

Speakers: Doctor L. Esposito, Ms V. Anfang, Doctor A. Aimo, Doctor H. Song, Doctor A. Gasecka...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk